Causal link between gut microbiome and schizophrenia: a Mendelian randomization study

被引:1
作者
Zeng, Qi [1 ]
Zhang, Min [1 ]
Wang, Renxi [1 ]
机构
[1] Capital Med Univ, Beijing Inst Brain Disorders, Collaborat Innovat Ctr Brain Disorders, Lab Brain Disorders,Minist Sci & Technol, 10 Xitoutiao, Beijing 100069, Peoples R China
基金
中国国家自然科学基金;
关键词
genetic variants; gut microbiome; GWAS; Mendelian randomization; schizophrenia; MAJOR DEPRESSIVE DISORDER; VITAMIN-D; GENETICS; ASSOCIATION; DISEASE; GENOME;
D O I
10.1097/YPG.0000000000000361
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
ObjectiveSome observational studies have shown that gut microbiome is significantly changed in patients with schizophrenia. We aim to identify the genetic causal link between gut microbiome and schizophrenia.MethodsA two-sample Mendelian randomization (MR) study was used to evaluate the causal link between gut microbiome and schizophrenia with 28 gut microbiome-associated genetic instrumental variants chosen from recent MR reports and the largest schizophrenia genome-wide association studies (8-Apr-22 release).ResultsInverse variance weighted method showed that genetically increased Bacteroidales_S24-7 (per SD) resulted in increased risk of schizophrenia (OR = 1.110, 95% CI: [1.012-1.217], P = 0.027). Similarly, genetically increased Prevotellaceae promoted schizophrenia risk (OR = 1.124, 95% CI: [1.030-1.228], P = 0.009). However, genetically increased Lachnospiraceae reduced schizophrenia risk (OR = 0.878, 95% CI: [0.785-0.983], P = 0.023). In addition, schizophrenia risk was also suppressed by genetically increased Lactobacillaceae (OR = 0.878, 95% CI: [0.776-0.994], P = 0.040) and Verrucomicrobiaceae (OR = 0.860, 95% CI: [0.749-0.987], P = 0.032). Finally, we did not find any significant results in the causal association of other 23 gut microbiome with schizophrenia.ConclusionOur analysis suggests that genetically increased Bacteroidales_S24-7 and Prevotellaceae promotes schizophrenia risk, whereas genetically increased Lachnospiraceae, Lactobacillaceae, and Verrucomicrobiaceae reduces schizophrenia risk. Thus, regulation of the disturbed intestinal microbiota may represent a new therapeutic strategy for patients with schizophrenia.
引用
收藏
页码:43 / 53
页数:11
相关论文
共 61 条
  • [1] Use of the second-generation antipsychotic, risperidone, and secondary weight gain are associated with an altered gut microbiota in children
    Bahr, S. M.
    Tyler, B. C.
    Wooldridge, N.
    Butcher, B. D.
    Burns, T. L.
    Teesch, L. M.
    Oltman, C. L.
    Azcarate-Peril, M. A.
    Kirby, J. R.
    Calarge, C. A.
    [J]. TRANSLATIONAL PSYCHIATRY, 2015, 5 : e652 - e652
  • [2] Role of the Microbiota in Immunity and Inflammation
    Belkaid, Yasmine
    Hand, Timothy W.
    [J]. CELL, 2014, 157 (01) : 121 - 141
  • [3] Calculating statistical power in Mendelian randomization studies
    Brion, Marie-Jo A.
    Shakhbazov, Konstantin
    Visscher, Peter M.
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2013, 42 (05) : 1497 - 1501
  • [4] Avoiding bias from weak instruments in Mendelian randomization studies
    Burgess, Stephen
    Thompson, Simon G.
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2011, 40 (03) : 755 - 764
  • [5] The Gut Microbiome and Mental Health: What Should We Tell Our Patients?: Le microbiote Intestinal et la Sante Mentale : que Devrions-Nous dire a nos Patients?
    Butler, Mary, I
    Moerkl, Sabrina
    Sandhu, Kiran, V
    Cryan, John F.
    Dinan, Timothy G.
    [J]. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2019, 64 (11): : 747 - 760
  • [6] THE MICROBIOTA-GUT-BRAIN AXIS
    Cryan, John F.
    O'Riordan, Kenneth J.
    Cowan, Caitlin S. M.
    Sandhu, Kiran V.
    Bastiaanssen, Thomaz F. S.
    Boehme, Marcus
    Codagnone, Martin G.
    Cussotto, Sofia
    Fulling, Christine
    Golubeva, Anna V.
    Guzzetta, Katherine E.
    Jaggar, Minal
    Long-Smith, Caitriona M.
    Lyte, Joshua M.
    Martin, Jason A.
    Molinero-Perez, Alicia
    Moloney, Gerard
    Morelli, Emanuela
    Morillas, Enrique
    O'Connor, Rory
    Cruz-Pereira, Joana S.
    Peterson, Veronica L.
    Rea, Kieran
    Ritz, Nathaniel L.
    Sherwin, Eoin
    Spichak, Simon
    Teichman, Emily M.
    van de Wouw, Marcel
    Ventura-Silva, Ana Paula
    Wallace-Fitzsimons, Shauna E.
    Hyland, Niall
    Clarke, Gerard
    Dinan, Timothy G.
    [J]. PHYSIOLOGICAL REVIEWS, 2019, 99 (04) : 1877 - 2013
  • [7] Antipsychotics and the gut microbiome: olanzapine-induced metabolic dysfunction is attenuated by antibiotic administration in the rat
    Davey, K. J.
    Cotter, P. D.
    O'Sullivan, O.
    Crispie, F.
    Dinan, T. G.
    Cryan, J. F.
    O'Mahony, S. M.
    [J]. TRANSLATIONAL PSYCHIATRY, 2013, 3 : e309 - e309
  • [8] NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis
    Elinav, Eran
    Strowig, Till
    Kau, Andrew L.
    Henao-Mejia, Jorge
    Thaiss, Christoph A.
    Booth, Carmen J.
    Peaper, David R.
    Bertin, John
    Eisenbarth, Stephanie C.
    Gordon, Jeffrey I.
    Flavell, Richard A.
    [J]. CELL, 2011, 145 (05) : 745 - 757
  • [9] Genetics of Schizophrenia: Ready to Translate?
    Foley, Claire
    Corvin, Aiden
    Nakagome, Shigeki
    [J]. CURRENT PSYCHIATRY REPORTS, 2017, 19 (09)
  • [10] The Gut Microbiota of Healthy Chilean Subjects Reveals a High Abundance of the Phylum Verrucomicrobia
    Fujio-Vejar, Sayaka
    Vasquez, Yessenia
    Morales, Pamela
    Magne, Fabien
    Vera-Wolf, Patricia
    Ugalde, Juan A.
    Navarrete, Paola
    Gotteland, Martin
    [J]. FRONTIERS IN MICROBIOLOGY, 2017, 8